PME — Pro Medicus Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$11.23bn
- AU$11.10bn
- AU$127.33m
- 100
- 2
- 98
- 72
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash from Operating Activities | 24.7 | 31.4 | 38.8 | 61.6 | 62.5 |
Capital Expenditures | -7.55 | -7.87 | -7.69 | -9.02 | -6.45 |
Purchase of Fixed Assets | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | 0.244 | 0.172 | -19.5 | -7.88 | -1.11 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -7.3 | -7.7 | -27.2 | -16.9 | -7.56 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -9.84 | -12.3 | -14 | -23.3 | -27.5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 7.08 | 11.1 | -1.37 | 21.6 | 27.6 |